Literature DB >> 22541558

Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome.

Francois P Bernier1, Oana Caluseriu, Sarah Ng, Jeremy Schwartzentruber, Kati J Buckingham, A Micheil Innes, Ethylin Wang Jabs, Jeffrey W Innis, Jane L Schuette, Jerome L Gorski, Peter H Byers, Gregor Andelfinger, Victoria Siu, Julie Lauzon, Bridget A Fernandez, Margaret McMillin, Richard H Scott, Hilary Racher, Jacek Majewski, Deborah A Nickerson, Jay Shendure, Michael J Bamshad, Jillian S Parboosingh.   

Abstract

Nager syndrome, first described more than 60 years ago, is the archetype of a class of disorders called the acrofacial dysostoses, which are characterized by craniofacial and limb malformations. Despite intensive efforts, no gene for Nager syndrome has yet been identified. In an international collaboration, FORGE Canada and the National Institutes of Health Centers for Mendelian Genomics used exome sequencing as a discovery tool and found that mutations in SF3B4, a component of the U2 pre-mRNA spliceosomal complex, cause Nager syndrome. After Sanger sequencing of SF3B4 in a validation cohort, 20 of 35 (57%) families affected by Nager syndrome had 1 of 18 different mutations, nearly all of which were frameshifts. These results suggest that most cases of Nager syndrome are caused by haploinsufficiency of SF3B4. Our findings add Nager syndrome to a growing list of disorders caused by mutations in genes that encode major components of the spliceosome and also highlight the synergistic potential of international collaboration when exome sequencing is applied in the search for genes responsible for rare Mendelian phenotypes.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541558      PMCID: PMC3376638          DOI: 10.1016/j.ajhg.2012.04.004

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Interaction of the BMPR-IA tumor suppressor with a developmentally relevant splicing factor.

Authors:  Tagvor G Nishanian; Todd Waldman
Journal:  Biochem Biophys Res Commun       Date:  2004-10-08       Impact factor: 3.575

2.  Microcephalic osteodysplastic primordial dwarfism type I with biallelic mutations in the RNU4ATAC gene.

Authors:  R Nagy; H Wang; B Albrecht; D Wieczorek; G Gillessen-Kaesbach; E Haan; P Meinecke; A de la Chapelle; J A Westman
Journal:  Clin Genet       Date:  2011-08-28       Impact factor: 4.438

3.  Autosomal recessive inheritance of Nager acrofacial dysostosis.

Authors:  J Chemke; B M Mogilner; I Ben-Itzhak; L Zurkowski; D Ophir
Journal:  J Med Genet       Date:  1988-04       Impact factor: 6.318

Review 4.  Regulated pre-mRNA splicing: the ghostwriter of the eukaryotic genome.

Authors:  Tracy L Johnson; Josep Vilardell
Journal:  Biochim Biophys Acta       Date:  2012-01-09

5.  Nager "syndrome" versus "anomaly" and its nosology with the postaxial acrofacial dysostosis syndrome of Genée and Wiedemann.

Authors:  J M Opitz
Journal:  Am J Med Genet       Date:  1987-08

6.  Differential diagnosis of Nager acrofacial dysostosis syndrome: report of four patients with Nager syndrome and discussion of other related syndromes.

Authors:  F Halal; J Herrmann; P D Pallister; J M Opitz; M F Desgranges; G Grenier
Journal:  Am J Med Genet       Date:  1983-02

7.  A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11).

Authors:  E N Vithana; L Abu-Safieh; M J Allen; A Carey; M Papaioannou; C Chakarova; M Al-Maghtheh; N D Ebenezer; C Willis; A T Moore; A C Bird; D M Hunt; S S Bhattacharya
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

8.  Acrofacial dysostoses.

Authors:  M Le Merrer; M Cikuli; J Ribier; M L Briard
Journal:  Am J Med Genet       Date:  1989-07

9.  Newly recognized autosomal recessive acrofacial dysostosis syndrome resembling Nager syndrome.

Authors:  Shelley J Kennedy; Ahmad S Teebi
Journal:  Am J Med Genet A       Date:  2004-08-15       Impact factor: 2.802

10.  Postaxial acrofacial dysostosis syndrome.

Authors:  M Miller; R Fineman; D W Smith
Journal:  J Pediatr       Date:  1979-12       Impact factor: 4.406

View more
  60 in total

Review 1.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

2.  Dysregulation of cotranscriptional alternative splicing underlies CHARGE syndrome.

Authors:  Catherine Bélanger; Félix-Antoine Bérubé-Simard; Elizabeth Leduc; Guillaume Bernas; Philippe M Campeau; Seema R Lalani; Donna M Martin; Stephanie Bielas; Amanda Moccia; Anshika Srivastava; David W Silversides; Nicolas Pilon
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

3.  Mutations in PIK3R1 cause SHORT syndrome.

Authors:  David A Dyment; Amanda C Smith; Diana Alcantara; Jeremy A Schwartzentruber; Lina Basel-Vanagaite; Cynthia J Curry; I Karen Temple; William Reardon; Sahar Mansour; Mushfequr R Haq; Rodney Gilbert; Ordan J Lehmann; Megan R Vanstone; Chandree L Beaulieu; Jacek Majewski; Dennis E Bulman; Mark O'Driscoll; Kym M Boycott; A Micheil Innes
Journal:  Am J Hum Genet       Date:  2013-06-27       Impact factor: 11.025

4.  SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant.

Authors:  Andrew Dauber; Christelle Golzio; Cécile Guenot; Francine M Jodelka; Maria Kibaek; Susanne Kjaergaard; Bruno Leheup; Danielle Martinet; Malgorzata J M Nowaczyk; Jill A Rosenfeld; Susan Zeesman; Janice Zunich; Jacques S Beckmann; Joel N Hirschhorn; Michelle L Hastings; Sebastien Jacquemont; Nicholas Katsanis
Journal:  Am J Hum Genet       Date:  2013-10-17       Impact factor: 11.025

Review 5.  Facial dysostoses: Etiology, pathogenesis and management.

Authors:  Paul A Trainor; Brian T Andrews
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

6.  GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK.

Authors:  P Y Billie Au; Jing You; A Micheil Innes; Antonie D Kline; Oana Caluseriu; Jeremy Schwartzentruber; Jacek Majewski; Francois P Bernier; Marcia Ferguson; David Valle; Jillian S Parboosingh; Nara Sobreira
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

7.  Component of splicing factor SF3b plays a key role in translational control of polyribosomes on the endoplasmic reticulum.

Authors:  Tomonori Ueno; Yuki Taga; Rei Yoshimoto; Akila Mayeda; Shunji Hattori; Kiyoko Ogawa-Goto
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-19       Impact factor: 11.205

Review 8.  Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

Authors:  Karla Terrazas; Jill Dixon; Paul A Trainor; Michael J Dixon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-02-10       Impact factor: 5.814

9.  Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.

Authors:  K Nicole Weaver; Kristin E Noack Watt; Robert B Hufnagel; Joaquin Navajas Acedo; Luke L Linscott; Kristen L Sund; Patricia L Bender; Rainer König; Charles M Lourenco; Ute Hehr; Robert J Hopkin; Dietmar R Lohmann; Paul A Trainor; Dagmar Wieczorek; Howard M Saal
Journal:  Am J Hum Genet       Date:  2015-04-23       Impact factor: 11.025

10.  WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.

Authors:  Shawna M Pyott; Thao T Tran; Dru F Leistritz; Melanie G Pepin; Nancy J Mendelsohn; Renee T Temme; Bridget A Fernandez; Solaf M Elsayed; Ezzat Elsobky; Ishwar Verma; Sreelata Nair; Emily H Turner; Joshua D Smith; Gail P Jarvik; Peter H Byers
Journal:  Am J Hum Genet       Date:  2013-03-14       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.